FTRE

Fortrea Holdings Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$9.45

Market Cap

$883.58M

Beta

1.78

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+1.00%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y-1.35%

P/E Ratio0.0

PEG Ratio—

FCF Yield+9.99%

Debt / Equity0.12

Interest Coverage-5.9x

No credit card required

Already have an account? Sign in to view the full analysis for FTRE.